Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Clinical Trials Network Award (CTNA)

Program Academic Research
RFA Status Open
Description

The Clinical Trials Network Award will be made to a institution, organization, or physician group with an established clinical trials infrastructure and clinical trials portfolio to develop and oversee a network of two cancer care facilities that currently lack access to clinical trials (stage 1). Once an initial network is satisfactorily demonstrated, the Lead Institution will be eligible to expand its network to two additional facilities located outside its current catchment (stage 2).

Award: Up to $600,000 annually for stage 1 and up to $900,000, annually for stage 2. Maximum duration: 4 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

Core Facility Support Awards (CFSA)

Program Academic Research
RFA Status Open
Description

Solicits applications from institutions to establish or enhance core facilities (laboratory, clinical, population-based, or computer-based) that will directly support cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer or improve quality of life for patients with and survivors of cancer. Institutions may submit 2 applications provided that 1 exclusively supports childhood cancer research.

Award: Up to $4,000,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

Early Clinical Investigator Award (ECI)

Program Academic Research
RFA Status Open
Description

Solicits applications from institutions to provide cancer physicians within the first 3 years of a faculty appointment as an assistant professor the opportunity to develop clinical research skills and to gain experience in advanced methods and experimental approaches needed to become successful clinical investigators. The award will protect time from clinical responsibilities to allow the early clinical investigator to develop and conduct investigator initiated clinical trials and to establish a partnership with a laboratory-based collaborator in order to design and conduct correlative studies needed to interpret the outcome of an interventional trial. The overall goal of this mechanism is to increase the pool of clinical investigators at Texas academic institutions who are conducting patient-oriented studies, capitalizing on basic discoveries and translating them through conduct of innovative clinical trials involving cancer patients or individuals at risk for cancer. Institutions may submit up to 2 applications.

Award: Up to $1,500,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

High-Impact/High-Risk Research Awards (HIHR)

Program Academic Research
RFA Status Open
Description

Provides short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers. Institutions may submit up to 5 applications

Award: Up to $250,000 (total costs); Maximum duration: 2 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

Texas Clinical Trials Participation Program Award (TCTPA)

Program Academic Research
RFA Status Open
Description

Solicits applications targeting projects to increase the number and diversity of subjects participating in therapeutic cancer clinical trials in Texas by removing non-clinical out of pocket costs as barriers to participation in cancer clinical trials for financially burdened subjects. Institutions or organizations conducting clinical trials are restricted to 1 application.

Award: Up to $1,500,000 (total costs); Maximum duration: 3 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

Texas Regional Excellence in Cancer Award (TREC)

Program Academic Research
RFA Status Open
Description

Solicits applications to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of peer reviewed cancer research funding. This mechanism is open to Texas institution whose campus is located > 100 mi from an NCI Designated Cancer Center. The award will support an established investigator to lead a program with a cohesive theme relevant to the cancer problems of the region and 3 to 5 research projects. In addition, funds maybe requested to support recruitment of new junior faculty, shared resources, and partnerships with established Texas cancer research programs to provide mentorship and access to facilities or expertise.

Award: Up to $6,000,000 (total costs); Maximum duration: 5 years.

Review Cycle Fiscal Year 2021 - Cycle 2
RFA Release August 05, 2020
Application Receipt September 16, 2020 - January 27, 2021
Application Review January 2021 - August 2021
Award Notification August 2021

Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations

Instructions for Applicants

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the coordination and expansion of evidence based services to prevent cancer in underserved populations who do not have adequate access to cancer prevention interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community and use evidence-based models shown to work in similar communities to prevent and control these cancers.

Read More

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release August 03, 2020
Application Receipt August 17, 2020 - October 05, 2020
Application Review November 2020 - April 2021
Award Notification May 2021

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 23, 2020
Application Receipt June 23, 2020 - June 21, 2021
Application Review Continuous
Award Notification Continuous

Research Training Awards

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports applications for integrated institutional research training programs to support promising individuals who seek specialized training in the area of cancer research. Successful applicant institutions are expected to provide trainees with broad access to research opportunities across disciplinary lines and to maintain high standards for intellectual rigor and creativity.

Award: Up to $800,000 per year in total costs; Maximum duration: 5 years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release June 18, 2020
Application Receipt July 08, 2020 - October 28, 2020
Application Review February 2021 - May 2021
Award Notification May 2021